The RDIF has also partnered with Dr Reddy's Lab to supply 100 million doses of its COVID-19 vaccine in development.
The phase 3 trials will be conducted in 19 sites across 10 states, including in cities such as Delhi, Mumbai, Patna and Lucknow and would seek to enroll 28,500 volunteers aged 18 years and above.
Oxford COVID-19 vaccine: Panel recommends that DCGI grant Serum Institute permission for human trials
The DCGI had earlier asked SII to clearly define Phase 2 and Phase 3 of trials and resubmit their application for evaluation.
COVID-19 treatment: Fabiflu by Glenmark, HCQ, Remdesivir and other drugs that are being used to treat coronavirus patients
Favipiravir is an antiviral drug which was developed by a Japanese pharma company, Fujifilm Toyama Chemical, to treat influenza.
GJEPC denies four-fold surge in imports of cut and polished diamonds, says there has actually been a 4.3% decline
Actual imports of cut and polished diamonds for this period stand at $1,527.43 million, and represent a decline of 14.44 percent as compared to $1,785.17 million for April-November 2016.